Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
JNJ News
Despite ongoing legal battles related to its talc products, Johnson & Johnson JNJ stock has climbed over 23% year-to-date. CNBC’s Jim Cramer on Thursday attrib...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson & Johnson's JNJ Inlexzo (gemcitabine intravesical system) as a new treatment approach f...
Johnson & Johnson JNJ on Tuesday won regulatory approval for its drug delivery product Inlexzo to treat high-risk non-muscle invasive bladder cancer, a mileston...
Analyst ratings
58%
of 26 ratingsMore JNJ News
Healthcare Johnson & Johnson gains approval of gemcitabine for local delivery into bladder Sep. 09, 2025 5:07 PM ET Johnson & Johnson (JNJ) Stock By: Jonathan B...
Johnson & Johnson announced the U.S. FDA approved INLEXZO, a new, potentially practice-changing approach for treating patients with certain types of bladder can...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Johnson & Johnson appoints former Sherwin-Williams CEO to its board of directors Sep. 09, 2025 4:07 AM ET Johnson & Johnson (JNJ) Stock, JNJ:CA Stock By: Meghav...
Johnson & Johnson (JNJ) announced that John Morikis, retired Chairman, President and Chief Executive Officer of The Sherwin-Williams Company (SHW), has been ele...